ParaPharma Boldo 300 Lab Test Results

Parapharma Boldo 300 (boldenone undecylenate)

Introduction

ParaPharma Boldo 300 is marketed as containing 300 mg/ml of boldenone undecylenate and is presented in a 10-milliliter multidose vial. To ensure product transparency and verify its label claims, AnabolicLab procured samples of ParaPharma Boldo 300 and submitted them for independent laboratory testing.

The analysis, conducted by SIMEC AG, revealed that the product contained 270 mg/ml of boldenone undecylenate—90% of the declared dosage. While slightly under the label claim, the product demonstrated reasonable consistency. Additionally, the product was confirmed to be free from microbiological, yeast, or mold contamination, ensuring sterility. The analysis and sample submission were funded by AnabolicLab as part of its commitment to promoting transparency and harm reduction in the anabolic steroid market.


Product Overview

  • Manufacturer: ParaPharma
  • Product Name: Boldo 300
  • Active Ingredient: Boldenone Undecylenate
  • Batch Number: PARA002
  • Expiration Date: August 2022
  • Delivery Method: Injectable (10 mL multidose vial, 300 mg/mL as per label claim)
  • Specification: 300 mg/mL boldenone undecylenate

Sample Acquisition and Testing

  • Date Purchased: Between July 15, 2019, and August 29, 2019
  • Source: European-based internet supplier
  • Product Submitted By: AnabolicLab
  • Analysis Paid For By: AnabolicLab
  • Analysis Performed By: SIMEC AG
  • Date Received by Lab: August 29, 2019
  • Date Report Completed: October 15, 2019

Testing Results

  1. Quantitative Dosage Testing (HPLC-UV):
    • Claimed Dosage: 300 mg/mL
    • Measured Dosage: 270 mg/mL boldenone undecylenate
    • Accuracy: 90% (slightly below label claim)
  2. Microbiological Testing (TAMC and TYMC):
    • Result: No microbiological contamination detected

Summary

ParaPharma Boldo 300 was determined to contain 270 mg/ml boldenone undecylenate compared to the declared 300 mg/ml, representing 90% of the label claim. While slightly underdosed, the product demonstrated reasonable consistency and was free from contamination. By funding the analysis and submitting the samples, AnabolicLab highlights the importance of independent testing to ensure transparency and harm reduction in the anabolic steroid market.


Disclaimer: The information provided here is for educational and harm reduction purposes only. AnabolicLab does not endorse or promote the use of anabolic steroids or other controlled substances.

Discuss the ParaPharma Boldo 300 lab test results on the AnabolicLab Forum.

ParaPharma Boldo 300 Dosage Quantification Lab Results [PDF]
ParaPharma Boldo 300 Dosage Quantification Lab Results [PDF]
Does ParaPharma Boldo 300 contain 300 milligrams of boldenone undecylenate in each milliliter of solution? Is it free of microbiological, yeast and mold contamination? HPLC-UV, TAMC/TYMC (October 15, 2019) …
Size194.18 KB
Downloaded590 times
Last UpdatedNovember 6, 2019
Download